NIH-funded research NIH-funded research

Improving cognitive function in older adults with mild cognitive impairment using meditation and brain stimulation

Official title: Accelerating Cognitive Gains from Digital Meditation with Noninvasive Brain Stimulation: A Pilot Study in MCI

Funded at University of California, San Francisco · NIH-10783766 · Data updated 2026-11-12

This study is looking to help older adults with mild cognitive impairment feel better and think more clearly by using a gentle brain stimulation technique along with a special meditation program, and it aims to see how these methods can improve their memory, stress levels, sleep, and overall health.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startFebruary 15, 2023
Project endJanuary 31, 2026
Funding year2024
Award (this year)$524,623
NIH project number5R61AG080528-02
Project IDNIH-10783766 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults aged 21 and above who have been diagnosed with mild cognitive impairment.

Less likely to help

Patients with severe cognitive impairment or those not diagnosed with mild cognitive impairment may not benefit from this research.

What this research studies

This research aims to enhance cognitive abilities and overall wellbeing in older adults with mild cognitive impairment (MCI) through a combination of non-invasive brain stimulation and a unique digital meditation program called MediTrain. Participants will receive transcranial alternating current stimulation (tACS) while engaging in this closed-loop meditation, which is designed to target specific brain networks associated with attention. The study will involve a randomized controlled trial with 90 older adults, assessing improvements in cognition, stress, sleep, and biological markers of aging. By exploring this innovative approach, the research seeks to provide valuable insights into effective interventions for those at risk of progressing to Alzheimer's disease.

Why it matters

Potential benefit: If successful, this research could lead to new, effective treatments that improve cognitive function and quality of life for patients with mild cognitive impairment.

How similar studies have gone: While some studies have explored the combination of brain stimulation and meditation in younger populations, this specific approach in older adults with MCI is novel and has not been extensively tested.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Ziegler, David a — University of California, San Francisco
  • Study coordinator: Ziegler, David a

Related research

Other NIH-funded projects on the same topics.

  • How cancer cells use exosomes to evade the immune system

    This study is looking at how cancer cells use tiny bubbles called exosomes to hide proteins that can keep your immune system from fighting the tumor, and by figuring this out, the researchers hope to help doctors understand why some people respond well to cancer treatments while others don’t, ultimately aiming to creat

    NIH research University of California, San Francisco · San Francisco, United States · NIH-9869561

  • Reducing harm from smoking using electronic cigarettes

    This study is looking at whether using electronic cigarettes can be a safer option for people who smoke traditional cigarettes, by comparing the health effects and exposure to harmful substances between the two.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-9752505

  • Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis

    This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11644470

  • Cutaneous opioid signals in skin inflammation

    A mentor-identified clinician-researcher at UCSF is studying how natural skin opioids regulate itch and pain in inflammatory skin conditions like eczema and hidradenitis, with plans to map where these opioids come from and how they affect skin nerves.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11640034

  • Pooling international data to understand long-term bisphosphonate use and atypical femur fractures

    This project combines large patient datasets from multiple countries to understand how long-term bisphosphonate use relates to rare hip and thigh bone fractures, helping doctors and patients make safer treatment choices.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11638692

  • Airway cell and immune cell talks in lung transplant failure

    This grant tests how airway cells and immune cells interact to drive chronic rejection after lung transplant, with the goal of slowing or preventing scar-like damage.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11629839

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.